| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Recombinant Human IL-17A/F Heterodimer (CHO-expressed), CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 20 & 16 kDa, reducing conditions. MW (theoretical): 15.1 kDa (IL-17A) & 14.9 kDa (IL-17F). The Recombinant Human IL-17A/F Heterodimer (CHO-expressed) from R&D Systems is derived from CHO. The Recombinant Human IL-17A/F Heterodimer (CHO-expressed) has been validated for the following applications: Bioactivity. |
|---|
| Size | 10 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | CTLA8, CTLA8cytotoxic T-lymphocyte-associated serine esterase 8, Cytotoxic T-lymphocyte-associated antigen 8, Cytotoxic T-Lymphocyte-Associated Protein 8, IL17, IL-17, IL-17A, interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8), interleukin 17A, interleukin-17A |
|---|
| Gene, Accession, CAS # | Gene ID: 3605, Accession: Q16552 (IL-17A) & Q96PD4 (IL-17F) |
|---|
| Catalog # | 5837-IL-010 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human IL-17A/F Heterodimer (CHO-expressed), CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 26558442 |
|---|
| 產(chǎn)品資料 |
|
|